ロード中...
AB014. S3A-3. Precision medicine on the horizon for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a molecularly heterogenous group of tumors, and tumor genotyping efforts have uncovered multiple actionable targets in both intrahepatic and extrahepatic tumors. IDH1 mutations, FGFR2 fusions, and BRAF V600E mutations are among the most promising targets to date in CCA-sp...
保存先:
| 出版年: | Hepatobiliary Surg Nutr |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421165/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|